|
|
| (20 intermediate revisions by 12 users not shown) |
| label / nl | label / nl |
| | | Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals |
| label / ast | label / ast |
| | | Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals |
| description / pt | description / pt |
| artigo científico | | artigo científico (publicado na 2014) |
| description / pt-br | description / pt-br |
| artigo científico | | artigo científico (publicado na 2014) |
| description / hy | description / hy |
| գիտական հոդված | | 2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված |
| description / uk | description / uk |
| наукова стаття | | наукова стаття, опублікована у вересні 2014 |
| description / ast | description / ast |
| artículu científicu | | artículu científicu espublizáu en 2014 |
| description / da | description / da |
| videnskabelig artikel | | videnskabelig artikel (udgivet 2014) |
| description / fr | description / fr |
| article scientifique | | article scientifique (publié 2014) |
| description / hyw | description / hyw |
| | | 2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած |
| description / fa | description / fa |
| | | مقالهٔ علمی |
| description / ur | description / ur |
| | | سائنسی مضمون |
| Property / author name string | |
| Michael A Eller
| |
| Property / author name string: Michael A Eller / rank | |
| Normal rank
| |
| Property / author name string: Michael A Eller / qualifier | |
| | |
| Property / author name string: Michael A Eller / reference | |
| | |
| Property / author name string | |
| Jeffrey R Currier
| |
| Property / author name string: Jeffrey R Currier / rank | |
| Normal rank
| |
| Property / author name string: Jeffrey R Currier / qualifier | |
| | |
| Property / author name string: Jeffrey R Currier / reference | |
| | |
| Property / author name string | |
| Mary A Marovich
| |
| Property / author name string: Mary A Marovich / rank | |
| Normal rank
| |
| Property / author name string: Mary A Marovich / qualifier | |
| | |
| Property / author name string: Mary A Marovich / reference | |
| | |
| Property / author name string | |
| Hannah N Kibuuka
| |
| Property / author name string: Hannah N Kibuuka / rank | |
| Normal rank
| |
| Property / author name string: Hannah N Kibuuka / qualifier | |
| | |
| Property / author name string: Hannah N Kibuuka / reference | |
| | |
| Property / author name string | |
| Richard A Koup
| |
| Property / author name string: Richard A Koup / rank | |
| Normal rank
| |
| Property / author name string: Richard A Koup / qualifier | |
| | |
| Property / author name string: Richard A Koup / reference | |
| | |
| Property / author name string | |
| Merlin L Robb
| |
| Property / author name string: Merlin L Robb / rank | |
| Normal rank
| |
| Property / author name string: Merlin L Robb / qualifier | |
| | |
| Property / author name string: Merlin L Robb / reference | |
| | |
| Property / author name string | |
| Nelson L Michael
| |
| Property / author name string: Nelson L Michael / rank | |
| Normal rank
| |
| Property / author name string: Nelson L Michael / qualifier | |
| | |
| Property / author name string: Nelson L Michael / reference | |
| | |
| Property / author name string | |
| Jerome H Kim
| |
| Property / author name string: Jerome H Kim / rank | |
| Normal rank
| |
| Property / author name string: Jerome H Kim / qualifier | |
| | |
| Property / author name string: Jerome H Kim / reference | |
| | |
| Property / author name string | |
| Silvia Ratto-Kim
| |
| Property / author name string: Silvia Ratto-Kim / rank | |
| Normal rank
| |
| Property / author name string: Silvia Ratto-Kim / qualifier | |
| | |
| Property / author name string: Silvia Ratto-Kim / reference | |
| | |
| Property / cites work |
| | | |
| Property / cites work: Immunology. Immune activation with HIV vaccines / rank |
| | | Normal rank |
| Property / cites work: Immunology. Immune activation with HIV vaccines / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors / rank |
| | | Normal rank |
| Property / cites work: Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine / rank |
| | | Normal rank |
| Property / cites work: Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system / rank |
| | | Normal rank |
| Property / cites work: History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. / rank |
| | | Normal rank |
| Property / cites work: Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study) / rank |
| | | Normal rank |
| Property / cites work: Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study) / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine / rank |
| | | Normal rank |
| Property / cites work: Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va / rank |
| | | Normal rank |
| Property / cites work: Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study / rank |
| | | Normal rank |
| Property / cites work: Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine / rank |
| | | Normal rank |
| Property / cites work: Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection / rank |
| | | Normal rank |
| Property / cites work: Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate / rank |
| | | Normal rank |
| Property / cites work: Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Novel adenovirus vector-based vaccines for HIV-1 / rank |
| | | Normal rank |
| Property / cites work: Novel adenovirus vector-based vaccines for HIV-1 / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. / rank |
| | | Normal rank |
| Property / cites work: Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. / rank |
| | | Normal rank |
| Property / cites work: Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection / rank |
| | | Normal rank |
| Property / cites work: Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand / rank |
| | | Normal rank |
| Property / cites work: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Glycerol monolaurate prevents mucosal SIV transmission / rank |
| | | Normal rank |
| Property / cites work: Glycerol monolaurate prevents mucosal SIV transmission / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial / rank |
| | | Normal rank |
| Property / cites work: Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands / rank |
| | | Normal rank |
| Property / cites work: Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections / rank |
| | | Normal rank |
| Property / cites work: Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells / rank |
| | | Normal rank |
| Property / cites work: HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans / rank |
| | | Normal rank |
| Property / cites work: Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection. / rank |
| | | Normal rank |
| Property / cites work: Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract / rank |
| | | Normal rank |
| Property / cites work: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein / rank |
| | | Normal rank |
| Property / cites work: Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes / rank |
| | | Normal rank |
| Property / cites work: Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity / rank |
| | | Normal rank |
| Property / cites work: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. / rank |
| | | Normal rank |
| Property / cites work: Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. / reference |
| | | |
| Property / author |
| | | |
| Property / author: Silvia Ratto-Kim / rank |
| | | Normal rank |
| Property / author: Silvia Ratto-Kim / qualifier |
| | | |
| Property / author: Silvia Ratto-Kim / qualifier |
| | | |
| Property / author |
| | | |
| Property / author: Merlin L Robb / rank |
| | | Normal rank |
| Property / author: Merlin L Robb / qualifier |
| | | |
| Property / author: Merlin L Robb / qualifier |
| | | |
| Property / author: Merlin L Robb / reference |
| | | |
| Property / author |
| | | |
| Property / author: Nelson Michael / rank |
| | | Normal rank |
| Property / author: Nelson Michael / qualifier |
| | | |
| Property / author: Nelson Michael / qualifier |
| | | |
| Property / author: Nelson Michael / reference |
| | | |
| Property / author |
| | | |
| Property / author: Jeffrey R Currier / rank |
| | | Normal rank |
| Property / author: Jeffrey R Currier / qualifier |
| | | |
| Property / author: Jeffrey R Currier / qualifier |
| | | |
| Property / author: Jeffrey R Currier / reference |
| | | |
| Property / author |
| | | |
| Property / author: Jerome H Kim / rank |
| | | Normal rank |
| Property / author: Jerome H Kim / qualifier |
| | | |
| Property / author: Jerome H Kim / qualifier |
| | | |
| Property / author: Jerome H Kim / reference |
| | | |
| Property / author |
| | | |
| Property / author: Richard A Koup / rank |
| | | Normal rank |
| Property / author: Richard A Koup / qualifier |
| | | |
| Property / author: Richard A Koup / qualifier |
| | | |
| Property / author: Richard A Koup / reference |
| | | |
| Property / author |
| | | |
| Property / author: Mary A Marovich / rank |
| | | Normal rank |
| Property / author: Mary A Marovich / qualifier |
| | | |
| Property / author: Mary A Marovich / qualifier |
| | | |
| Property / author: Mary A Marovich / reference |
| | | |
| Property / author |
| | | |
| Property / author: Michael A Eller / rank |
| | | Normal rank |
| Property / author: Michael A Eller / qualifier |
| | | |
| Property / author: Michael A Eller / qualifier |
| | | |
| Property / author: Michael A Eller / reference |
| | | |
| Property / author |
| | | |
| Property / author: Hannah Kibuuka / rank |
| | | Normal rank |
| Property / author: Hannah Kibuuka / qualifier |
| | | |
| Property / author: Hannah Kibuuka / qualifier |
| | | |
| Property / author: Hannah Kibuuka / reference |
| | | |
| Property / ResearchGate publication ID |
| | | |
| Property / ResearchGate publication ID: 265418211 / rank |
| | | Normal rank |
| Property / ADS bibcode |
| | | |
| Property / ADS bibcode: 2014PNAS..11113439H / rank |
| | | Normal rank |